Trial record 1 of 2 for:
Triheptanoin | Huntington+Disease
A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease (TRIHEP3)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02453061 |
Recruitment Status :
Completed
First Posted : May 25, 2015
Last Update Posted : August 25, 2021
|
Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator:
Ultragenyx Pharmaceutical Inc
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 3, 2019 |
Actual Study Completion Date : | December 3, 2019 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):